About the Project
In this PhD, we will employ routine cell and molecular biology techniques to study the enzymatic independent functions of HDAC6 in cell proliferation and migration. You will gain experience in protein over-expression techniques, the study of protein-protein interactions, intracellular signalling and a variety of in vitro assays to measure key hallmarks of tumorigenesis and drug responses in cancer cells. This is an exciting collaboration between Drs Fiona Furlong and Irina Tikhonova who’s expertise in receptor pharmacology and molecular modelling aim to design a new class of HDAC inhibitor drugs.
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.
A whole-genome CRISPR screening approach to identify key genes involved in hypoxia-induced inhibition of cell death in muscle-invasive bladder cancer cells that can then be used to improve the efficacy of radiotherapy and chemotherapy
The University of Manchester